Biopharma Daily Stock Updates - 03/04/21

$XBI $135.43 -3.22% 📉

COVID Updates

$APLS (+0.29%) Apellis will not pursue additional development of APL-9 for severe COVID-19 source


Pipeline Updates

$GLPG (+3.11%) Report primary endpoint results in MANTRA and MANTRA-Ray safety studies source

$KRON (+3.02%) Positive End-of-Phase 2 meeting with FDA for Entospletinib source

$GLYC (-2.94%) First patient dosed in China phase 1 APL-106 trial source

$LUMO (-5.82%) Published data supporting use of predictive enrichment markers for LUM-201 in Journal of the Endocrine Society source

$OCUL (-1.37%) Acceptance of sNDA for Dextenza for ocular itching associated with allergic conjunctivitis source

$ALXO (-3.15%) ALX Oncology and Tallac Therapeutics Announce Collaboration on Novel Class of Cancer Immunotherapeutics source


Financial Updates

$ENDP (+0.58%) Commence refinancing of existing term loan source

$SLDB (-10.72%) Inducement Grant to New Chief Legal Officer source

$AMGN (-0.91%) Amgen to acquire Five Prime Therapeutics source

$GILD (+0.77%) Gilead completes acquisition of MYR GmbH source

$RDHL (-3.35%) Closing of public offering of 4,375,000 ADSs source

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE